TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
KPTI

Karyopharm Therapeutics Inc

Healthcare · Biotechnology

1.70$ -1.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

Karyopharm Therapeutics Inc (KPTI) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -75 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow KPTI
Line item 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-8.5 -16 -30 -51 -94 -84 -74 -159 -191 -160 -107 -150 -93 -127 -75
0.1 0.1 0.1 0.3 0.6 0.7 0.7 0.7 1.0 1.0 0.8 0.6 0.5 0.3 -0.1
0.0 0.7 3.8 14 17 22 20 17 15 24 30 35 22 18 14
– – 3.8 14 17 22 20 17 15 24 37 35 – – –
1.7 -0.4 -0.4 9.7 4.0 1.0 33 -0.2 -13 1.4 -23 -20 31 -0.3 28
0.4 0.1 0.1 2.8 1.4 0.1 0.1 2.4 0.2 0.1 5.7 0.1 0.0 0.1 0.0
-0.4 -0.1 -0.1 -67 -91 25 17 -108 78 -54 142 -104 7.9 95 43
– – 0.0 0.0 0.0 0.0 0.0 – – – – – – – –
– – 113 113 0.6 0.6 0.9 3.5 4.5 10 3.7 4.0 – 111 –
– – – – 167 167 167 167 – – – 0.0 0.0 83 27
12 9.5 186 113 93 51 76 316 124 172 74 194 1.1 42 30
3.1 -6.1 156 -5.4 -92 -8.7 19 49 12 -42 108 -61 -84 9.6 -1.9
-8.9 -16 -30 -54 -95 -84 -74 -161 -191 -160 -113 -150 -93 -128 -75

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?